Market revenue in 2023 | USD 717.5 million |
Market revenue in 2030 | USD 960.6 million |
Growth rate | 4.3% (CAGR from 2023 to 2030) |
Largest segment | Carbohydrates |
Fastest growing segment | Carbohydrates |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Carbohydrates, Proteins, Polymers, Minerals, Glycoside & Waxes, Esters, Ethers & Carboxylic Acids, Other Chemical Natures |
Key market players worldwide | Basf SE, Lonza Group Ltd, Evonik Industries AG, Roquette America, JRS Pharma, Micro Powders, Fumeipharm, Cristalco |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plant-based excipients market will help companies and investors design strategic landscapes.
Carbohydrates was the largest segment with a revenue share of 21.11% in 2023. Horizon Databook has segmented the North America plant-based excipients market based on carbohydrates, proteins, polymers, minerals, glycoside & waxes, esters, ethers & carboxylic acids, other chemical natures covering the revenue growth of each sub-segment from 2018 to 2030.
North America is one of the major pharmaceutical markets. The high healthcare spending and increase in the number of research studies in the region for drugs also support the demand for plant-based excipients in the market.
The rising awareness among the population regarding health and advantages offered by natural excipients, such as non-toxicity, high affordability, and easy availability, are further driving the growth of the regional market.
Moreover, key players in the region are focusing on developing newer products to meet the rising demand for pharmaceuticals. For instance, in December 2022, Evonik announced the launch of Phyto Squene, which provides the market with a plant-based excipient alternative to animal-based excipients.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America plant-based excipients market , including forecasts for subscribers. This continent databook contains high-level insights into North America plant-based excipients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account